TAK-875 Placebo

DRUG3 trials

Sponsors

Takeda

Conditions

Cardiovascular DiseaseDiabetes Mellitus, Type 2Type 2 DiabetesType 2 Diabetes Mellitus

Phase 3

Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease

TerminatedNCT01609582

TakedaCardiovascular Disease, Type 2 Diabetes

Start: 2012-06-30End: 2014-05-31Updated: 2015-10-19

Study to Evaluate the Efficacy and Safety of Daily Oral TAK-875 25 and 50mg in Asia Pacific Adults With Type 2 Diabetes

TerminatedNCT01647542

TakedaType 2 Diabetes Mellitus

Start: 2012-10-31End: 2014-03-31Updated: 2015-11-11

Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 Diabetes

TerminatedNCT01829477

TakedaDiabetes Mellitus, Type 2

Start: 2013-04-30End: 2014-02-28Updated: 2016-06-01